Unverified50% confidenceFactExact time
Although anti-amyloid drugs can significantly reduce plaque burden in clinical trials, cognitive improvement is often limited.
1
Sources
50%
Confidence
Long-term
Relevance
10/24/2026
First Seen
Sources
Related Entities
Related Claims
UnverifiedAnti-Aβ antibody drugs developed based on the amyloid hypothesis have repeatedly stumbled in clinical trials, either failing to significantly improve cognition or being forced to terminate due to side effects such as brain edema.73% similarUnverifiedAntidepressants beat placebos with statistically significant advantages in controlled studies, but this does not necessarily equate to clinically meaningful improvement71% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/1092211API
curl https://kongchang.com/api/v1/knowledge/claims/1092211MCP
get_claim(id=1092211)